Search results

Filter

Filetype

Your search for "*" yielded 563176 hits

What makes us human? The answer may be found in overlooked DNA

Our DNA is very similar to that of the chimpanzee, which in evolutionary terms is our closest living relative. Stem cell researchers at Lund University in Sweden have now found a previously overlooked part of our DNA, so-called non-coded DNA, that appears to contribute to a difference which, despite all our similarities, may explain why our brains work differently. The study is published in the jo

https://www.multipark.lu.se/article/what-makes-us-human-answer-may-be-found-overlooked-dna - 2026-07-17

PhD defence interview - Nadja Gustavsson

During her thesis project, Nadja Gustavsson has characterized structural changes inside neurons of a new mouse model for mixed neurogenerative disorders. On the 21st of October, she is defending her thesis supervised by Oxana Klementieva. In this interview, Nadja shares her ups and downs during her time as a Ph.D. student in MultiPark. Tell us about your Ph.D. research! Our lab utilizes a novel ap

https://www.multipark.lu.se/article/phd-defence-interview-nadja-gustavsson - 2026-07-17

Meningitis: Researchers find possible treatment strategy without antibiotics

Meningitis is a very serious brain infection with limited treatment options. In a new study performed in rats, researchers from the University of Copenhagen present an alternative treatment based on immune cells that helps rinse away toxins that accumulate during the infection. Fever, headache, confusion, seizures, amputations, or death. Meningitis is a very serious brain infection that can affect

https://www.multipark.lu.se/article/meningitis-researchers-find-possible-treatment-strategy-without-antibiotics - 2026-07-17

A young MultiParkers working group takes shape

Collaboration, networking, career development, and wellbeing. Those are four examples of needs that the newly formed young MultiParkers working group will address. After organizing their first event, they are eager to start preparing for more events. During the pandemic, there has been an upbuild of need for social gathering and exchange of ideas and experiences. Especially young researchers who r

https://www.multipark.lu.se/article/young-multiparkers-working-group-takes-shape - 2026-07-17

Nine MultiPark scientists granted support from the Swedish Research Council

Receiving grants from the Swedish Research Council is viewed as a quality mark and one of the critical steps for young scientists to establish an independent research group. Last week, nine of MultiPark’s research leaders were awarded 31.6 million SEK for their projects. This year’s support from the Swedish Research Council encouraged MultiPark’s ambition to be a multidisciplinary research area. P

https://www.multipark.lu.se/article/nine-multipark-scientists-granted-support-swedish-research-council - 2026-07-17

Ph.D. defence interview - Jonathan Timpka

During his research education, Jonathan Timpka wanted to elucidate what is affecting the ability to work for patients diagnosed with Parkinson’s disease. Defending his Ph.D. thesis on November 19th, Jonathan tells about his wide range of projects within the Restorative Parkinson Unit led by Per Odin. Tell us about your Ph.D. research! My research engagement has been quite diverse, ranging from reg

https://www.multipark.lu.se/article/phd-defence-interview-jonathan-timpka - 2026-07-17

Alzheimer’s awareness: Five research projects shaping the future of understanding, diagnosis and care

With over 15 research groups dedicated to Alzheimer’s disease research, MultiPark’s goal is to understand the origins of the disease, develop early diagnostics, and improve treatments. The multidisciplinary approach sheds light on the disease from several angles, bridging basic research with clinical investigations. Here are five projects. September is World Alzheimer’s Month. Globally, around 40

https://www.multipark.lu.se/article/alzheimers-awareness-five-research-projects-shaping-future-understanding-diagnosis-and-care - 2026-07-17

Why repetitive DNA matters for human brain evolution and disease

For decades, large stretches of human DNA were dismissed as ‘junk’ and considered to serve no real purpose. In a new study in Cell Genomics, researchers at Lund University in Sweden show that the repetitive part of the human genome plays an active role during early brain development and may also be relevant for understanding brain diseases. DNA carries the complete set of instructions an organism

https://www.multipark.lu.se/article/why-repetitive-dna-matters-human-brain-evolution-and-disease - 2026-07-17

TIME to unite lab and clinic – 1.5 million € to build an AI model of Alzheimer’s disease

Enormous amounts of data about Alzheimer’s Disease have been generated from clinical studies so far. Still, the molecular drivers of Alzheimer’s Disease are largely unknown. With the TAU-TIME project, Jacob Vogel aims to advance knowledge by developing an AI tool that brings together known biological mechanisms with data from patients with the disease. Recent funding from the European Research Cou

https://www.multipark.lu.se/article/time-unite-lab-and-clinic-15-million-eu-build-ai-model-alzheimers-disease - 2026-07-17

Smell test cuts need for invasive Parkinson’s screening

Early diagnosis is key to receiving proper care and advancing research on future therapies for neurodegenerative diseases such as Parkinson’s and dementia with Lewy bodies. New research from Skåne University Hospital and Lund University shows that combining a simple smell test with advanced spinal fluid analysis can predict these diseases with high accuracy, while sparing nearly half of patients f

https://www.multipark.lu.se/article/smell-test-cuts-need-invasive-parkinsons-screening - 2026-07-17

New digital cognitive test for diagnosing Alzheimer's disease

Researchers at Lund University in Sweden have developed a digital cognitive test for diagnosing Alzheimer's disease that is intended for use in primary care. “This digital test, which patients perform on their own with minimal involvement from healthcare personnel, improves the primary care physician's ability to determine who should be further examined by blood tests for Alzheimer's pathology ear

https://www.multipark.lu.se/article/new-digital-cognitive-test-diagnosing-alzheimers-disease - 2026-07-17

Meet Our Scientists Podcast: Cecilia Lundberg about the gene workshop

What if brain diseases could be cured by turning on the proper genes? Meet our scientist, Professor Cecilia Lundberg! She explains how gene therapy may complement cell therapies to combat Parkinson’s disease. Cecilia Lundberg is head of the CNS Gene Therapy Research Group and has spent her whole career developing cutting-edge tools that may be used in future therapies to slow down or cure neurodeg

https://www.multipark.lu.se/article/meet-our-scientists-podcast-cecilia-lundberg-about-gene-workshop - 2026-07-17

Meet Our Scientists Podcast: Per Odin about the Parkinson’s journey

Have you ever wondered what the journey of someone living with Parkinson’s disease looks like? Meet our scientist, Professor Per Odin! He shares his experiences of the bumpy road faced by patients he has supported over the years, both in healthcare and in research studies. Parkinson’s disease is a long, challenging course; one that science works tirelessly to understand, where halting neurodegener

https://www.multipark.lu.se/article/meet-our-scientists-podcast-odin-about-parkinsons-journey - 2026-07-17

Largest ever TauPET study of Alzheimer’s deepens understanding of the disease

In a study led by Lund University and the Amsterdam University Medical Center, researchers used PET to analyse aggregates of tau pathology in more than 12,000 people from all over the world. The study – the largest ever of its kind – examines the connection between genetic predisposition, gender and age in relation to tau pathology in Alzheimer’s disease. The study is published in Nature Neuroscie

https://www.multipark.lu.se/article/largest-ever-taupet-study-alzheimers-deepens-understanding-disease - 2026-07-17

MultiPark scientists awarded prestigious VR consolidator grant

With an approval rate of just 17 %, this year’s Swedish Research Council grants were harder than usual to secure. Still, several of MultiPark’s group leaders were awarded major grants in Medicine and Health 2025. Receiving grants from the Swedish Research Council is seen as a mark of quality and an important step in advancing an independent research group. Recently, six MultiPark researchers were

https://www.multipark.lu.se/article/multipark-scientists-awarded-prestigious-vr-consolidator-grant - 2026-07-17

MultiPark Researchers Recognized on Clarivate’s Highly Cited List

Nine researchers from MultiPark have been listed as Highly Cited Researchers by Clarivate, highlighting their significant global research impact. Clarivate acknowledges researchers whose publications rank among the top 1% most cited in their fields over the past eleven years. The selected scientists have published several highly-cited papers. Congratulations to Oskar Hansson, Shorena Janelidze, Sa

https://www.multipark.lu.se/article/multipark-researchers-recognized-clarivates-highly-cited-list - 2026-07-17

On a Journey of Discovery in Research: MultiPark Opens Labs to the Parkinson’s Association

Recently, MultiPark opened its doors to the local Parkinson’s Association, who were invited behind the scenes to see how research on their condition is conducted. Here are some of the laboratories that were visited. Today’s basic research on brain disorders such as Parkinson’s may be the starting point for tomorrow’s treatments. This may explain the participants’ deep interest in MultiPark’s exper

https://www.multipark.lu.se/article/journey-discovery-research-multipark-opens-labs-parkinsons-association - 2026-07-17

The Promobilia Foundation invests SEK 25 million in a new large-scale research project targeting Parkinson’s disease

The Promobilia Foundation is investing SEK 25 million in a new large-scale research project targeting Parkinson’s disease. The donation enables four research groups—one at Lund University and three at Karolinska Institutet—to join forces in developing new treatment strategies that address the root causes of the disease. Using innovative approaches, including advanced gene therapies and targeted ve

https://www.multipark.lu.se/article/promobilia-foundation-invests-sek-25-million-new-large-scale-research-project-targeting-parkinsons - 2026-07-17

How lifestyle and biology shape brain changes linked to dementia

Almost half of all dementia cases may be associated with modifiable factors such as smoking and high blood pressure. At the same time, some risk factors are built into our biology, such as age, sex, and genetics. But dementia is not a single disease, rather symptom of multiple underlying disorders. Therefore, risk factor profiles for various dementia subtypes are likely to vary. A new study highli

https://www.multipark.lu.se/article/how-lifestyle-and-biology-shape-brain-changes-linked-dementia - 2026-07-17

MultiPark Innovation Grants Have Generated Inventions Since 2011

Turning scientific knowledge into solutions that improve people’s lives is the ultimate goal of research. But the path from novel scientific data to an innovation that may impact health care is long; many promising ideas never get a fair chance. For 16 years, MultiPark Innovation has supported researchers in their first efforts in transforming discoveries into inventions that may benefit patients

https://www.multipark.lu.se/article/multipark-innovation-grants-have-generated-inventions-2011 - 2026-07-17